Shah Rukh Khan is currently basking in the sucess of his recently released film Jawan. Helmed by Atlee, the film went on to cross over 1000 crores at the ticket window. The superstar started the year with a bang after Pathaan shattered box office records. However, Vivek Agnihotri has a different opinion on King Khan’s recent films.
While speaking with Siddharth Kanan, Vivek Agnihotri dubbed Shah Rukh Khan’s latest films as ‘superficial’, “I think his recent films are very superficial. He can do far better than that. Haan jo bhi aai hai unke films (whichever films have released recently). Those that I have watched, I found them very superficial. They are okay at the level of an action film but to present them as a standard of filmmaking and that this is the end of show business, I don’t agree with that. Then I think it’s a sycophancy. I have a problem with that.”
Vivek Agnihotri had earlier hinted that even Shah Rukh Khan’s fans have also been abusing him amid Jawan’s success. Though the filmmaker did not take anybody’s name, he argued that another ‘huge Bollywood’ film’s fans are using his daughter’s photos and trolling him. “I am not saying don’t watch this and watch that,” he told the news portal.
Meanwhile, Vivek Agnihotri’s The Vaccine War was released on September 28. It talks about the struggle of Indian scientists that went behind the development of vaccines. The film stars Raima Sen, Anupam Kher, Nana Patekar, Sapthami Gowda, and Pallavi Joshi as lead characters. Produced by Pallavi Joshi and I Am Buddha, the film will be released in Hindi, Tamil and Telugu on September 28.
News18 Showsha’s review of The Vaccine War reads: “Despite its important messaging, The Vaccine War lacks the nuance and hard-hitting quotient of Vivek Agnihotri’s previous films, The Taskent Files and The Kashmir Files. It’s a simple plot without any risky arcs and unpredictable storytelling. We understand that it’s no thriller and is a commentary on professionals who left no stone unturned to save multiple lives during the health crisis and put India’s medical progress on the global map but it lacks a certain cinematic spark. The narrative doesn’t carry enough weight to keep you hooked throughout its 2 hours 41 minutes runtime. But mind you, the pace isn’t really the problem here, the cramming of too many incidents is. The problem isn’t so much with what it’s trying to say but how it’s told thus giving it a very bland finish.”